Skip to main content
. 2024 Jul 4;14(7):797. doi: 10.3390/biom14070797

Figure 13.

Figure 13

Nirmatrelvir, a covalent, reversible SARS-CoV-2 Mpro inhibitor, and examples of its structurally closely related compounds (maximum common substructure (MCS)) with known Mpro inhibitory activity from the PubChem Database. The low potency criterion was IC50 or Ki > 10 μM or Inh% at 20 μM < 75%.